162 related articles for article (PubMed ID: 24239942)
1. US trade agreement threatens to increase drug prices and withhold safety data.
Cohen D
BMJ; 2013 Nov; 347():f6908. PubMed ID: 24239942
[No Abstract] [Full Text] [Related]
2. India remains on US trade "priority watch list" for failing to uphold international drug company patents.
Arie S
BMJ; 2013 May; 346():f2949. PubMed ID: 23657189
[No Abstract] [Full Text] [Related]
3. Rx: higher prices.
Kosterlitz J
Natl J (Wash); 1993 Feb; 25(7):396-9. PubMed ID: 10125572
[TBL] [Abstract][Full Text] [Related]
4. Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad.
Luo J; Kesselheim AS
AMA J Ethics; 2016 Jul; 18(7):727-35. PubMed ID: 27437823
[TBL] [Abstract][Full Text] [Related]
5. Patents, pills and politics: the Australia-United States Free Trade Agreement and the Pharmaceutical Benefits Scheme.
Harvey K
Aust Health Rev; 2004 Nov; 28(2):218-26. PubMed ID: 15527402
[TBL] [Abstract][Full Text] [Related]
6. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
Baker BK
PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325
[TBL] [Abstract][Full Text] [Related]
7. The North American Free Trade Agreement's effect on pharmaceutical patents: a bitter pill to swallow or a therapeutic solution?
Silbermann JM
J Contemp Health Law Policy; 1996; 12(2):607-36. PubMed ID: 8666736
[No Abstract] [Full Text] [Related]
8. Pharmaceutical patents and some international trade issues: Canada, the United States, and NAFTA.
Tancer RS
Clin Ther; 1993; 15(6):1177-84; discussion 1120. PubMed ID: 8111813
[TBL] [Abstract][Full Text] [Related]
9. . . . and Brazilian AIDS programme threatened by US trade action.
Int J Epidemiol; 2001 Apr; 30(2):413. PubMed ID: 11369751
[No Abstract] [Full Text] [Related]
10. Introduction: pharmaceutical innovation: law & the public's health.
Outterson K
J Law Med Ethics; 2009; 37(2):173-5. PubMed ID: 19493064
[No Abstract] [Full Text] [Related]
11. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
12. Proposed trade agreement could increase patent protection for pharmaceuticals.
Eggertson L
CMAJ; 2013 Jul; 185(10):E459-60. PubMed ID: 23695601
[No Abstract] [Full Text] [Related]
13. The high price of "free" trade: U.S. trade agreements and access to medicines.
Lopert R; Gleeson D
J Law Med Ethics; 2013; 41(1):199-223. PubMed ID: 23581666
[TBL] [Abstract][Full Text] [Related]
14. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices.
Pinzone JD
J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775
[No Abstract] [Full Text] [Related]
15. Australian drugs scheme threatens free-trade talks.
Fickling D
Lancet; 2004 Jan; 363(9405):299. PubMed ID: 14753208
[No Abstract] [Full Text] [Related]
16. AIDS group takes aim at pharmaceutical firm's patents, prices.
AIDS Policy Law; 2002 Jul; 17(13):4. PubMed ID: 12162289
[No Abstract] [Full Text] [Related]
17. Pharmaceuticals, patents, and politics: Canada and Bill C-22.
Lexchin J
Int J Health Serv; 1993; 23(1):147-60. PubMed ID: 8425783
[TBL] [Abstract][Full Text] [Related]
18. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
19. Australia amends its free trade deal with US to lessen effect on drug costs.
Burton B
BMJ; 2004 Aug; 329(7463):420. PubMed ID: 15321891
[No Abstract] [Full Text] [Related]
20. US switch to first-to-file patents could cause minor shake-up.
Waters H
Nat Med; 2011 Aug; 17(8):906-7. PubMed ID: 21818070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
